50712-69-1

Usage

Uses

Used in Material Science:
2-(Bromomethyl)-5-Chlorobenzonitrile is used as a chemical intermediate for the synthesis of various materials, contributing to the development of new compounds and materials with specific properties in material science.
Used in Pharmaceutical Industry:
2-(Bromomethyl)-5-Chlorobenzonitrile is used as a key building block in the synthesis of pharmaceutical compounds, playing a crucial role in the development of new drugs and therapeutic agents.
Used in Chemical Research:
2-(Bromomethyl)-5-Chlorobenzonitrile is employed as a reagent in various chemical reactions, facilitating the exploration of new reaction pathways and the synthesis of novel chemical entities in the field of chemical research.

Upstream product

• 50712-70-4 5-chloro-2-methylbenzonitrile 

Downstream Products

• 658683-27-3 (4-chloro-2-cyano-benzyl)-di carbamic acid tert butyl ester 
• 1021873-80-2 5-chloro-1-(4-chloro-2-cyanobenzyl)-2-imino-1,2-dihydropyridine-3-carboxamide hydrochloride 
• 1427423-14-0 (E)-5-chloro-2-(4-chloro-2-fluorostyryl)benzonitrile 
• 1427423-15-1 5-chloro-2-(4-chloro-2-fluorophenethyl)benzonitrile 
• 1427423-16-2 5-chloro-2-(4-chloro-2-fluorophenethyl)benzaldehyde 
• 1427423-18-4 (E)-5-chloro-2-(4-chloro-2-fluorostyryl)benzaldehyde 
• 1427423-13-9 diethyl 4-chloro-2-cyanobenzylphosphonate 
• 1314945-59-9 (R)-1-[1-(4-chloro-2-cyanobenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-imidazo [4,5-b]pyridin-7-yl]piperidin-3-yl carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

BICYCLIC HETEROAROMATIC AMIDE COMPOUNDS AND USES THEREOF

The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

Ep1 receptor ligands

The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation,

EP1 RECEPTOR LIGANDS

The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.

FUSED PYRIDINE DERIVATIVES

Fused pyridine derivatives shown as the general formula (I), and their pharmaceutically acceptable salts, stereoisomers or solvates thereof are disclosed, which belong to the technical field of medicines. The R1, R2, R3, Q, X and Y substituents in formula (I) are defined as in the description. Also disclosed are the preparation methods, pharmaceutical compositions comprising the compounds and uses of the compounds in the manufacture of the medicine for the treatment and/or prevention of noninsulin-dependent diabetes, hyperglycemia, hyperlipidemia and insulin resistance.

FUSED PYRIDINE DERIVATIVES

Fused pyridine derivatives shown as the general formula (I), and their pharmaceutically acceptable salts, stereoisomers or solvates thereof are disclosed, which belong to the technical field of medicines. The R1, R2, R3, Q, X and Y substituents in formula (I) are defined as in the description. Also disclosed are the preparation methods, pharmaceutical compositions comprising the compounds and uses of the compounds in the manufacture of the medicine for the treatment and/or prevention of noninsulin-dependent diabetes, hyperglycemia, hyperlipidemia and insulin resistance.

AROMATIC COMPOUND

An aromatic compound represented by the following formula or a pharmaceutically acceptable salt thereof: , wherein ring A is a heterocyclic ring, ring B is a carbocyclic ring, a heterocyclic ring etc., G1, G2, G3, G4 and G5 are CH or N, X is -NH-, -O-, -CH2-, etc., Y is - CH2-,-CO-,-SO2- etc., Z is a single bond, -CO-, -SO2-, -NH-, -O-, -S-, -CONH-,-SO2NH-, etc., R2 is hydrogen, alkyl, alkoxy, halogen, etc., and R3 is carbocyclic group, heterocyclic group, alkyl, etc., is useful as a controlling agent of the function of CCR4 useful for the treatment or therapy for bronchial asthma, atopic dermatitis, etc.

AMINE-LINKED PYRIDYL AND PHENYL SUBSTITUTED PIPERAZINE-PIPERIDINES WITH CXCR3 ANTAGONIST ACTIVITY

The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts, solvates or esters of said compound, or of said prodrug, said compound having th